4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-16-131273
Chief Executive Officer acquired 15,772 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2016-06-30 | Option exercise | +15,772 | $5.09 | $80,279 | 1,117,233 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2016-06-30 | Option exercise · Common Stock Warrant | −15,772 | 0 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…